These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33996404)

  • 1. Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles.
    Yaghmur A; Mu H
    Acta Pharm Sin B; 2021 Apr; 11(4):871-885. PubMed ID: 33996404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cubosomes and Hexosomes as Novel Nanocarriers for Bioactive Compounds.
    Tan C; Hosseini SF; Jafari SM
    J Agric Food Chem; 2022 Feb; 70(5):1423-1437. PubMed ID: 35089018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cubosomes and hexosomes as versatile platforms for drug delivery.
    Azmi ID; Moghimi SM; Yaghmur A
    Ther Deliv; 2015; 6(12):1347-64. PubMed ID: 26652281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse ISAsomes in Bio-Compatible Oils-Exploring Formulations in Squalane, Triolein and Olive Oil.
    Trummer F; Glatter O; Chemelli A
    Nanomaterials (Basel); 2022 Mar; 12(7):. PubMed ID: 35407249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine.
    Zhai J; Fong C; Tran N; Drummond CJ
    ACS Nano; 2019 Jun; 13(6):6178-6206. PubMed ID: 31082192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature triggering of kinetically trapped self-assemblies in citrem-phospholipid nanoparticles.
    Prajapati R; Salentinig S; Yaghmur A
    Chem Phys Lipids; 2018 Nov; 216():30-38. PubMed ID: 30222973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems.
    Leu JSL; Teoh JJX; Ling ALQ; Chong J; Loo YS; Mat Azmi ID; Zahid NI; Bose RJC; Madheswaran T
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cubosomes and hexosomes for the delivery of phenytoin to the brain.
    Mohammad Y; Prentice RN; Boyd BJ; Rizwan SB
    J Colloid Interface Sci; 2022 Jan; 605():146-154. PubMed ID: 34311309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structurally diverse library of safe-by-design citrem-phospholipid lamellar and non-lamellar liquid crystalline nano-assemblies.
    Azmi ID; Wibroe PP; Wu LP; Kazem AI; Amenitsch H; Moghimi SM; Yaghmur A
    J Control Release; 2016 Oct; 239():1-9. PubMed ID: 27524284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.
    Chountoulesi M; Pispas S; Tseti IK; Demetzos C
    Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanocarriers in drug delivery: characterization and design.
    Mu H; Holm R
    Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Lamellar Liquid Crystalline Nanocarriers for Thymoquinone Encapsulation.
    Yaghmur A; Tran BV; Moghimi SM
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31861549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.
    Chavda VP; Dyawanapelly S; Dawre S; Ferreira-Faria I; Bezbaruah R; Rani Gogoi N; Kolimi P; Dave DJ; Paiva-Santos AC; Vora LK
    Int J Pharm; 2023 Nov; 647():123546. PubMed ID: 37884213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell interactions with lipid nanoparticles possessing different internal nanostructures: Liposomes, bicontinuous cubosomes, hexosomes, and discontinuous micellar cubosomes.
    Yap SL; Yu H; Li S; Drummond CJ; Conn CE; Tran N
    J Colloid Interface Sci; 2024 Feb; 656():409-423. PubMed ID: 38000253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and potential applications of nanostructured aqueous dispersions.
    Yaghmur A; Glatter O
    Adv Colloid Interface Sci; 2009; 147-148():333-42. PubMed ID: 18804754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioimaging Applications of Non-Lamellar Liquid Crystalline Nanoparticles.
    Murgia S; Biffi S; Fornasier M; Lippolis V; Picci G; Caltagirone C
    J Nanosci Nanotechnol; 2021 May; 21(5):2742-2759. PubMed ID: 33653441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling in vitro cell culture with synchrotron SAXS to understand the bio-interaction of lipid-based liquid crystalline nanoparticles with vascular endothelial cells.
    Lam YY; Hawley A; Tan A; Boyd BJ
    Drug Deliv Transl Res; 2020 Jun; 10(3):610-620. PubMed ID: 31997254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Microfluidic Production of Citrem-Phosphatidylcholine Nano-Self-Assemblies for Thymoquinone Delivery.
    Ilhan-Ayisigi E; Ghazal A; Sartori B; Dimaki M; Svendsen WE; Yesil-Celiktas O; Yaghmur A
    Nanomaterials (Basel); 2021 Jun; 11(6):. PubMed ID: 34200457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes to Cubosomes: The Evolution of Lipidic Nanocarriers and Their Cutting-Edge Biomedical Applications.
    Attri N; Das S; Banerjee J; Shamsuddin SH; Dash SK; Pramanik A
    ACS Appl Bio Mater; 2024 May; 7(5):2677-2694. PubMed ID: 38613498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cubosomes as versatile lipid nanocarriers for neurological disorder therapeutics: a comprehensive review.
    A Vahab S; Nair A; Raj D; G P A; P P S; S Kumar V
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3729-3746. PubMed ID: 38095651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.